← Back to Discover
JAY JEFFREY R
Period ended Jun 30, 2013 · Latest filing Aug 14, 2013
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2013: $126,545,000
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2013. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- HYPERION THERAPEUTICS INC. · COM · 44915N101 · shares: $21,207,000
- FURIEX PHARMACEUTICAL, INC. · COM · 36106P101 · shares: $16,834,000
- STEMLINE THERAPEUTICS INC. · COM · 85858C107 · shares: $14,196,000
- BIODEL INC. · COM · 09064M204 · shares: $7,749,000
- AMBIT BIOSCIENCES CORP · COM · 02318X100 · shares: $7,000,000
- GERON CORPORATION · COM · 374163103 · shares: $5,625,000
- PAIN THERAPEUTICS INC. · COM · 69562K100 · shares: $5,133,000
- SUNSHINE HEART INC. · COM · 86782U106 · shares: $5,101,000
- DURATA THERAPEUTICS INC. · COM · 26658A107 · shares: $4,604,000
- NORDION INC. · COM · 65563C105 · shares: $3,978,000
Reported holdings
32 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| HYPERION THERAPEUTICS INC. | COM | 44915N101 | — | 963,961 shares | $21,207,000 |
| FURIEX PHARMACEUTICAL, INC. | COM | 36106P101 | — | 494,100 shares | $16,834,000 |
| STEMLINE THERAPEUTICS INC. | COM | 85858C107 | — | 595,493 shares | $14,196,000 |
| BIODEL INC. | COM | 09064M204 | — | 1,853,845 shares | $7,749,000 |
| AMBIT BIOSCIENCES CORP | COM | 02318X100 | — | 1,000,000 shares | $7,000,000 |
| GERON CORPORATION | COM | 374163103 | — | 3,750,000 shares | $5,625,000 |
| PAIN THERAPEUTICS INC. | COM | 69562K100 | — | 2,322,769 shares | $5,133,000 |
| SUNSHINE HEART INC. | COM | 86782U106 | — | 950,000 shares | $5,101,000 |
| DURATA THERAPEUTICS INC. | COM | 26658A107 | — | 639,433 shares | $4,604,000 |
| NORDION INC. | COM | 65563C105 | — | 537,500 shares | $3,978,000 |
| HORIZON PHARMA, INC. | COM | 44047T109 | — | 1,596,720 shares | $3,928,000 |
| ONCOGENEX PHARMACEUTICAL INC. | COM | 68230A106 | — | 347,004 shares | $3,401,000 |
| IMPAX LABORATORIES, INC. | COM | 45256B101 | PUT | 150,000 shares | $2,991,000 |
| TRINITY BIOTECH PLC | SPON ADR NEW | 896438306 | — | 163,140 shares | $2,749,000 |
| RTI BIOLOGICS, INC. | COM | 74975N105 | — | 673,898 shares | $2,534,000 |
| DYAX CORP | COM | 26746E103 | — | 728,063 shares | $2,519,000 |
| MAST THERAPEUTICS INC. | COM | 576314108 | — | 5,800,000 shares | $2,490,000 |
| PROTALIX BIOTHERAPEUTICS INC. | COM | 74365A101 | — | 399,007 shares | $1,959,000 |
| MYRIAD GENETICS INC. | COM | 62855J104 | PUT | 70,000 shares | $1,881,000 |
| VOLCANO CORPORATION | COM | 928645100 | — | 100,000 shares | $1,813,000 |
| TARGACEPT, INC. | COM | 87611R306 | — | 367,709 shares | $1,570,000 |
| AVANIR PHARMACEUTICALS INC. | CL A NEW | 05348P401 | CALL | 258,600 shares | $1,190,000 |
| XENOPORT INC. | COM | 98411C100 | — | 232,977 shares | $1,153,000 |
| MEI PHARMA INC. | COM NEW | 55279B202 | — | 157,661 shares | $1,124,000 |
| PERNIX THERAPEUTICS HOLDINGS | COM | 71426V108 | — | 297,187 shares | $1,073,000 |
| PALATIN TECHNOLOGIES INC. | COM | 696077403 | — | 1,712,807 shares | $1,062,000 |
| VASCULAR SOLUTIONS INC. | COM | 92231M109 | — | 46,200 shares | $680,000 |
| WRIGHT MEDICAL GROUP, INC. | RIGHT 03/01/2019 | 98235T115 | — | 200,000 shares | $542,000 |
| CELSION CORPORATION | COM | 15117N305 | — | 186,200 shares | $190,000 |
| CRYOLIFE INC. | COM | 228903100 | — | 26,244 shares | $164,000 |
| GW PHARMACEUTICALS PLC | ADS | 36197T103 | — | 11,622 shares | $102,000 |
| AMAG PHARMACEUTICALS, INC. | COM | 00163U106 | — | 150 shares | $3,000 |